Theresa Eagleson, HFS Director | https://hfs.illinois.gov/about/director.html
Theresa Eagleson, HFS Director | https://hfs.illinois.gov/about/director.html
Illinois Department of Healthcare and Family Services Drugs and Therapeutics Advisory Board met Aug. 1.
Here is the agenda provided by the board:
I. Call to Order
II. Roll Call
III. Announcements
IV. Agenda and Conflict of Interest Review
V. Approval of the Minutes
VI. PDL Drug Appeals
a. Rexulti
b. Caplyta
VII. New Drug Appeals
a. None for this meeting
VIII. Drug Class Review- Jen Phillips, PharmD clinical review (with discussion and vote)
a. Diabetic Rescue Medications
b. Antiasthmatics-Monoclonal Antibodies
c. Overactive Bladder Medications
IX. New Drug Initial Review-Jen Phillips, PharmD clinical review (with discussion and vote)
a. Ogsiveo
b. Rezdiffra
c. Simlandi
d. Zurzuvae
e. Opsynvi
X. Public Comments
XI. Future Agenda Preview -Sheri Dolan
• D&T Advisory Board Meeting Dates 2025
XII. Provider Requested Reviews-Sheri Dolan
a. None for this meeting
XIII. Department Update-Jose Jimenez
XIV. Adjournment
https://hfs.illinois.gov/content/dam/soi/en/web/hfs/sitecollectiondocuments/dtadvisoryboardagenda08012024.pdf
Alerts Sign-up